The NKG2 A/NKG2 B Type II Integral Membrane Protein pipeline drugs market research report outlays comprehensive information on the NKG2 A/NKG2 B Type II Integral Membrane Protein targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the NKG2 A/NKG2 B Type II Integral Membrane Protein pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Oncology, and Infectious Disease which include the indications Solid Tumor, Unspecified Cancer, Human Immunodeficiency Virus (HIV) Infections (AIDS), and Coronavirus Disease 2019 (COVID-19). It also reviews key players involved in NKG2 A/NKG2 B Type II Integral Membrane Protein targeted therapeutics development with respective active and dormant or discontinued products.
The NKG2 A/NKG2 B Type II Integral Membrane Protein pipeline targets constitutes close to 13 molecules. Out of which, approximately 12 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Phase I, IND/ CTA Filed, Preclinical, and Discovery stages are 2, 2, 1, 1, 4, and 2 respectively. Similarly, the universities portfolio in Discovery comprises 1 molecule.
NKG2 A/NKG2 B Type II Integral Membrane Protein overview
NKG2A and NKG2B (Natural Killer Group 2 member A and member B) are related type II integral membrane proteins that are part of the C-type lectin-like receptor family. These proteins play a role in the regulation of natural killer (NK) cell function and are involved in immune responses.
For a complete picture of NKG2 A/NKG2 B Type II Integral Membrane Protein’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.